Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.

J Psychiatr Res 2015 Jan 8;60:40-8. Epub 2014 Oct 8.

Department of Chemical Engineering and Biotechnology, University of Cambridge, Tennis Court Road, Cambridge CB21QT, UK; Department of Neuroscience, Erasmus MC, NL-3015 GE Rotterdam, The Netherlands. Electronic address:

Disturbances of the hypothalamic-pituitary-adrenal axis have been implicated in the pathophysiology of bipolar disorder (BD) and major depressive disorder (MDD). To examine this further, we carried out proteomic profiling of post-mortem pituitaries from 13 BD and 14 MDD patients, in comparison to 15 controls. Liquid chromatography-mass spectrometry (LC-MS(E)) analysis showed that BD patients had significantly increased levels of the major pituitary hormones pro-opiomelanocortin (POMC) and galanin. BD patients also showed changes in proteins associated with gene transcription, stress response, lipid metabolism and growth signalling. In contrast, LC-MS(E) profiling revealed that MDD patients had significantly decreased levels of the prohormone-converting enzyme carboxypeptidease E and follow-up enzymatic analysis showed decreased activity of prolyl-oligopeptidase convertase. This suggested that altered prohormone processing may occur in pituitaries of MDD patients. In addition, MDD patients had significant changes in proteins involved in intracellular transport and cytoskeletal signalling. Finally, we carried out selective reaction monitoring (SRM) mass spectrometry profiling for validation of protein changes in key biological pathways. This confirmed increased POMC levels in BD patients with no change in the levels of this prohormone in MDD. This study demonstrates that proteomic profiling analysis of the pituitary can lead to new insights into the pathophysiology of BD and MDD. Also, given that the pituitary directly releases a variety of bioactive molecules into the bloodstream, many of the proteins identified here could serve as focal points in the search for peripheral biomarkers in clinical or drug treatment studies of BD and MDD patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2014.09.022DOI Listing
January 2015

Publication Analysis

Top Keywords

mdd patients
20
patients
9
pituitaries mdd
8
patients changes
8
changes proteins
8
major depressive
8
bipolar disorder
8
depressive disorder
8
mdd
8
disorder major
8
proteomic profiling
8
intracellular transport
4
patients addition
4
addition mdd
4
proteins involved
4
involved intracellular
4
transport cytoskeletal
4
signalling finally
4
srm mass
4
mass spectrometry
4

Similar Publications